News

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...
The Moderna layoffs are aimed at cutting costs amid declining vaccine sales and a shifting regulatory landscape.
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
The company last reported total revenues of $108M in Q1, down 35.3% Y/Y due to lower net product sales, particularly its ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...